UFPT News & Events

Other 3-5 year financial targets include 28%-31% gross margin and 17%-20% operating margin. Comments taken from investor presentation slides.

Reports Q4 revenue $148.915M, consensus $149.07M. "I am pleased with our 2025 results and our progress on a number of key strategic initiatives," said R. Jeffrey Bailly, CEO. "Sales for the year grew 19.5% to $602.8 million, operating income grew 14.1% to $92.3 million, and EPS grew 15.4% to $8.75. Our growth was driven by a 23.2% increase in medical sales, partially offset by an 11.5% decrease in non-medical sales."

UFP Technologies announced that R. Jeffrey Bailly will retire as CEO at the Company's next annual meeting on June 4, 2026. At that time, Mitchell Rock, President of the Company, will assume the CEO position and join the Company's Board. To facilitate a smooth transition, Bailly will serve as Executive Chairman of the Board for the following year.

Reports Q3 revenue $154.56M, consensus $149.56M. "I am pleased with our third quarter results and continued progress with our strategic initiatives," said R. Jeffrey Bailly, chairman and CEO. "Sales grew 6.5%, with a 7.3% increase in our MedTech sales offset by a 2.7% decline in our non-medical business. EPS was $2.11 per share, equal to last year. Strong operating results offset roughly $3 million in incremental labor costs at our Illinois AJR facility related to a post-acquisition review of our labor force's eligibility to work under US laws. Absent this expense, EPS would have increased 13%. We expect the impact in Q4 will be significantly less as our new E-Verified employees continue to improve their efficiency."